Metalabs Co., Ltd.

KSE 090370.KS

Metalabs Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 6.07 M

Metalabs Co., Ltd. Current Liabilities is USD 6.07 M for the year ending December 31, 2023, a -13.14% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Metalabs Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 6.99 M, a -67.33% change year over year.
Metalabs Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 21.39 M, a 42.48% change year over year.
Metalabs Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 15.01 M, a -29.20% change year over year.
Metalabs Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 21.21 M, a -18.67% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

KSE: 090370.KS

Metalabs Co., Ltd.

CEO	Mr. Dong Keun Kim
IPO Date	Dec. 26, 2006
Location	South Korea
Headquarters	Mojerim Building
Employees	20
Sector	Health Care
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies

Description

Metalabs Co., Ltd. primarily provides clothing in South Korea. It also manufactures and distributes prescription drugs, medical devices, and masks; develops peptide-based bio products; offers medical management services; and distributes cosmetics, as well as operates dating applications. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was founded in 2000 and is based in Seoul, South Korea.

Key trends

Past 5 years